These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25945833)

  • 1. hERG1/Kv11.1 activation stimulates transcription of p21waf/cip in breast cancer cells via a calcineurin-dependent mechanism.
    Perez-Neut M; Rao VR; Gentile S
    Oncotarget; 2016 Sep; 7(37):58893-58902. PubMed ID: 25945833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium channel activation inhibits proliferation of breast cancer cells by activating a senescence program.
    Lansu K; Gentile S
    Cell Death Dis; 2013 Jun; 4(6):e652. PubMed ID: 23744352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the small molecule HERG activator NS1643 on Kv11.3 channels.
    Bilet A; Bauer CK
    PLoS One; 2012; 7(11):e50886. PubMed ID: 23226420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
    Hu M; Wang J; Chen P; Reilly RM
    Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of Kv11.1 activators on Kv11.1a, Kv11.1b and Kv11.1a/Kv11.1b channels.
    Larsen AP; Bentzen BH; Grunnet M
    Br J Pharmacol; 2010 Oct; 161(3):614-28. PubMed ID: 20880400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic model for NS1643 drug activation of WT and L529I variants of Kv11.1 (hERG1) potassium channel.
    Perissinotti LL; Guo J; De Biase PM; Clancy CE; Duff HJ; Noskov SY
    Biophys J; 2015 Mar; 108(6):1414-1424. PubMed ID: 25809254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of hERG3 channel stimulates autophagy and promotes cellular senescence in melanoma.
    Perez-Neut M; Haar L; Rao V; Santha S; Lansu K; Rana B; Jones WK; Gentile S
    Oncotarget; 2016 Apr; 7(16):21991-2004. PubMed ID: 26942884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potassium channel activity controls breast cancer metastasis by affecting β-catenin signaling.
    Breuer EK; Fukushiro-Lopes D; Dalheim A; Burnette M; Zartman J; Kaja S; Wells C; Campo L; Curtis KJ; Romero-Moreno R; Littlepage LE; Niebur GL; Hoskins K; Nishimura MI; Gentile S
    Cell Death Dis; 2019 Feb; 10(3):180. PubMed ID: 30792401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of hERG1 channel activity promotes a calcium-dependent degradation of cyclin E2, but not cyclin E1, in breast cancer cells.
    Perez-Neut M; Shum A; Cuevas BD; Miller R; Gentile S
    Oncotarget; 2015 Jan; 6(3):1631-9. PubMed ID: 25596745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical study of a Kv11.1 potassium channel activator as antineoplastic approach for breast cancer.
    Fukushiro-Lopes DF; Hegel AD; Rao V; Wyatt D; Baker A; Breuer EK; Osipo C; Zartman JJ; Burnette M; Kaja S; Kouzoukas D; Burris S; Jones WK; Gentile S
    Oncotarget; 2018 Jan; 9(3):3321-3337. PubMed ID: 29423049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-guided topographic mapping and mutagenesis to elucidate binding sites for the human ether-a-go-go-related gene 1 potassium channel (KCNH2) activator NS1643.
    Durdagi S; Guo J; Lees-Miller JP; Noskov SY; Duff HJ
    J Pharmacol Exp Ther; 2012 Aug; 342(2):441-52. PubMed ID: 22573844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Activation of the Kv11.1 Channel Reprograms EMT in Colon Cancer by Inhibiting TGFβ Signaling via Activation of Calcineurin.
    Eskandari N; Senyuk V; Moore J; Kalik Z; Luan Q; Papautsky I; Moshiri A; Bocchetta M; Salami SA; Oryan S; Gentile S
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo.
    Takeuchi S; Takahashi A; Motoi N; Yoshimoto S; Tajima T; Yamakoshi K; Hirao A; Yanagi S; Fukami K; Ishikawa Y; Sone S; Hara E; Ohtani N
    Cancer Res; 2010 Nov; 70(22):9381-90. PubMed ID: 21062974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.
    Choi YH; Yoo YH
    Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compensatory expression of NRF2-dependent antioxidant genes is required to overcome the lethal effects of Kv11.1 activation in breast cancer cells and PDOs.
    Senyuk V; Eskandari N; Jiang Y; Garcia-Varela R; Sundstrom R; Leanza L; Peruzzo R; Burkard M; Minshall RD; Gentile S
    Redox Biol; 2021 Sep; 45():102030. PubMed ID: 34147842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of the hSNF5 gene concomitantly inactivates p21CIP/WAF1 and p16INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells.
    Chai J; Charboneau AL; Betz BL; Weissman BE
    Cancer Res; 2005 Nov; 65(22):10192-8. PubMed ID: 16288006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent activation of large-conductance Ca2+-activated K+ channels by the diphenylurea 1,3-bis-[2-hydroxy-5-(trifluoromethyl)phenyl]urea (NS1643) in pituitary tumor (GH3) cells.
    Wu SN; Peng H; Chen BS; Wang YJ; Wu PY; Lin MW
    Mol Pharmacol; 2008 Dec; 74(6):1696-704. PubMed ID: 18809671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant adenovirus-p21 attenuates proliferative responses associated with excessive scarring.
    Gu D; Atencio I; Kang DW; Looper LD; Ahmed CM; Levy A; Maneval D; Zepeda ML
    Wound Repair Regen; 2005; 13(5):480-90. PubMed ID: 16176456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Activation of Potassium Channel Kv11.1 with NS1643 Attenuates Triple Negative Breast Cancer Cell Migration by Promoting the Dephosphorylation of Caveolin-1.
    Jiang Y; Senyuk V; Ma K; Chen H; Qin X; Li S; Liu Y; Gentile S; Minshall RD
    Cells; 2022 Aug; 11(15):. PubMed ID: 35954304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
    Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
    J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.